Fresenius Organizational Structure & Org Chart
Fresenius currently manages Fresenius Kabi and Fresenius Helios as fully owned operating companies. Fresenius Medical Care is a separately listed company in which Fresenius holds around 29 percent.
Fresenius organizational chart
Duplicate and edit this Fresenius chart
Fresenius's reporting structure as of 2026-09. Drag to pan, scroll to zoom — or open it in QueryChart and edit it as your own.
- Industry
- Healthcare products and hospitals
- Headquarters
- Bad Homburg, Germany
- Founded
- 1912
- Employees
- 178,394 (31 Dec 2025)
- CEO
- Michael Sen
- Revenue
- €22.9 billion reported (FY2025)
- Ownership
- Public
- Structure as of
- 2026-09
- Structure last reviewed
- 2026-09-24
About the company
Fresenius currently manages Fresenius Kabi and Fresenius Helios as fully owned operating companies. Fresenius Medical Care is a separately listed company in which Fresenius holds around 29 percent.
Fresenius Medical Care was deconsolidated in 2023 and is accounted for under the equity method. The chart separates that stake and residual VIACAMA activities from the two fully consolidated operating companies; it does not recreate the old four-segment Fresenius diagram.
How Fresenius is organized
Fresenius Kabi supplies biopharmaceuticals, clinical nutrition, MedTech, generic IV drugs and IV fluids. Fresenius Helios operates healthcare providers in Germany and Spain.
Helios Germany includes hospitals and outpatient medical centers. Helios Spain runs hospitals and outpatient facilities and also has activities in Latin America.
Fresenius Medical Care is an investment rather than a fully owned operating segment. The former Vamed activity is under a structured exit and its remaining business is called VIACAMA.
Key leadership roles
Michael Sen
Chief executive, Fresenius — The chart depicts operating-company ownership and separate investment interest, not unreported personal reporting lines.
How this structure supports the business
The split between consolidated businesses and investment interests prevents FMC from appearing wholly owned.
Kabi products and Helios care delivery remain visibly different economic activities.
Advantages and disadvantages
- The operating-company ownership and separate investment interest view follows the company's public disclosure.
- A tree cannot show every cross-company function, joint venture or legal entity.
Interesting facts
- Fresenius Kabi and Fresenius Helios are each described as 100-percent-owned operating companies.
- Fresenius reported around 29 percent in FMC in its 2025 report.
- FMC was deconsolidated in 2023.
- Fresenius Vamed is no longer a reporting segment.
Related organization charts
- Merck KGaA Organizational Structure & Org Chart
- Evonik Organizational Structure & Org Chart
- Fresenius Medical Care Organizational Structure & Org Chart
- Siemens Healthineers Organizational Structure & Org Chart
- Sartorius Organizational Structure & Org Chart
- B. Braun Organizational Structure & Org Chart
- Bayer Organizational Structure & Divisions
- BASF Organizational Structure & Business Segments
Frequently asked questions
What are Fresenius's main businesses?
Fresenius Kabi, Fresenius Helios, Fresenius Medical Care stake, VIACAMA remaining activities.
What relationship does this Fresenius chart show?
It shows operating-company ownership and separate investment interest from the cited company disclosures, with selected activities placed below their published groupings.
Is this a complete legal or employee reporting chart?
No. The diagram stops at the last public level verified in the cited sources.
Use this org chart template
Open the dated structure in QueryChart and adapt its divisions, brands and connections to your own organization.
